Incidence and prevalence estimates vary slightly depending on the methodology, but commonly cited figures are that approximately one-third of Americans have symptoms of acute or intermittent insomnia, and that approximately 10% have chronic insomnia.…

Since 1987 when zopiclone (Somnosan, Zimovane, Imovane, Rhovane, Ximovan) was introduced into clinical practice, extensive evaluations have shown that some rebound changes can be detected in healthy individuals. In patients with insomnia more than 20…

Benzodiazepines became widely available for medical purposes in the 1960s and replaced barbiturates in treatments of many conditions. Benzodiazepines proved themselves less prone to abuse than barbiturates, in addition to being safer — accidental overdose…

Depression is a brain disorder. It can affect your thoughts, moods, feelings, behavior, and physical health. Unfortunately, many people still think it is “all in your head” and that if the person would only try harder, he or she could snap out of…

The antidepressants are used to relieve the symptoms of depression, which may include feelings of sadness, helplessness, loss of interest in usual activities, insomnia, loss of energy, problems concentrating, weight loss or gain, and decreased desire…

Zopiclone is the generic name of a prescription sleep aid developed by Sepracor and introduced in 1988. Zopiclone helps you get to sleep faster and sleep with fewer interuptions. It is available in about 85 countries worldwide and marketed under various…

Here’s an extract of an interview with Dr. Lisa Williams of Montgomery Pulmonary Consultants. She regularly sees people in sleep labs suffering from sleep apnea and insomnia.

On March 18, 2010, Somaxon Pharmaxeuticals (SOMX) was granted FDA approval to sell Silenor 3 and 6 mg. tablets for the treatment of insomnia characterized by difficulty with sleep maintenance. This approval was met with a stock price move from 4 to 10…

The drug, MK-4305, helped patients sleep for a larger percentage of eight hours spent in bed at one night and at the end of four weeks of treatment, Merck said. The drug also demonstrated superiority to placebo in the time it took to fall asleep and time…